PDB-3fts: Leukotriene A4 hydrolase in complex with resveratrol Method: X-RAY DIFFRACTION / Resolution: 2.33 Å
PDB-3ftu: Leukotriene A4 hydrolase in complex with dihydroresveratrol Method: X-RAY DIFFRACTION / Resolution: 1.9 Å
PDB-3ftv: Leukotriene A4 hydrolase in complex with fragment N-(pyridin-3-ylmethyl)aniline Method: X-RAY DIFFRACTION / Resolution: 1.7 Å
PDB-3ftw: Leukotriene A4 hydrolase in complex with fragments N-(pyridin-3-ylmethyl)aniline and acetate Method: X-RAY DIFFRACTION / Resolution: 1.85 Å
PDB-3ftx: Leukotriene A4 hydrolase in complex with dihydroresveratrol and bestatin Method: X-RAY DIFFRACTION / Resolution: 1.96 Å
PDB-3fty: Leukotriene A4 hydrolase in complex with fragment 3-(benzyloxy)pyridin-2-amine Method: X-RAY DIFFRACTION / Resolution: 2.15 Å
PDB-3fu0: Leukotriene A4 hydrolase in complex with fragment 4-(4-fluorobenzoyl)pyridine Method: X-RAY DIFFRACTION / Resolution: 1.8 Å
PDB-3fu3: Leukotriene A4 hydrolase in complex with fragment 4-(2-amino-1,3-thiazol-4-yl)phenol Method: X-RAY DIFFRACTION / Resolution: 2 Å
PDB-3fu5: Leukotriene A4 hydrolase in complex with (5-thiophen-2-ylthiophen-2-yl)methylamine Method: X-RAY DIFFRACTION / Resolution: 2.3 Å
PDB-3fu6: Leukotriene A4 hydrolase in complex with fragment (4-thiophen-2-ylphenyl)methanamine Method: X-RAY DIFFRACTION / Resolution: 2.05 Å
PDB-3fud: Leukotriene A4 hydrolase in complex with N-methyl-1-(2-thiophen-2-ylphenyl)methanamine Method: X-RAY DIFFRACTION / Resolution: 2.2 Å
PDB-3fue: Leukotriene A4 hydrolase in complex with fragment 5-chloroindole and bestatin Method: X-RAY DIFFRACTION / Resolution: 2.38 Å
PDB-3fuf: Leukotriene A4 hydrolase in complex with fragment 5-fluoroindole and bestatin Method: X-RAY DIFFRACTION / Resolution: 2.6 Å
PDB-3fuh: Leukotriene A4 hydrolase in complex with fragment 5-hydroxyindole and bestatin Method: X-RAY DIFFRACTION / Resolution: 1.8 Å
PDB-3fui: Leukotriene A4 hydrolase in complex with N-benzyl-4-[(2R)-pyrrolidin-2-ylmethoxy]aniline Method: X-RAY DIFFRACTION / Resolution: 2.2 Å
PDB-3fuj: Leukotriene A4 hydrolase in complex with 5-[2-(1H-pyrrol-1-yl)ethoxy]-1H-indole Method: X-RAY DIFFRACTION / Resolution: 1.9 Å
PDB-3fuk: Leukotriene A4 hydrolase in complex with 1-[2-(1H-indol-5-yloxy)ethyl]piperidine-4-carboxylic acid Method: X-RAY DIFFRACTION / Resolution: 1.95 Å
PDB-3fum: Leukotriene A4 hydrolase in complex with (R)-pyridin-4-yl[4-(2-pyrrolidin-1-ylethoxy)phenyl]methanol Method: X-RAY DIFFRACTION / Resolution: 2.15 Å
PDB-3fun: Leukotriene A4 hydrolase in complex with {4-[(2R)-pyrrolidin-2-ylmethoxy]phenyl}(4-thiophen-3-ylphenyl)methanone Method: X-RAY DIFFRACTION / Resolution: 1.58 Å
In the structure databanks used in Yorodumi, some data are registered as the other names, "COVID-19 virus" and "2019-nCoV". Here are the details of the virus and the list of structure data.
Jan 31, 2019. EMDB accession codes are about to change! (news from PDBe EMDB page)
EMDB accession codes are about to change! (news from PDBe EMDB page)
The allocation of 4 digits for EMDB accession codes will soon come to an end. Whilst these codes will remain in use, new EMDB accession codes will include an additional digit and will expand incrementally as the available range of codes is exhausted. The current 4-digit format prefixed with “EMD-” (i.e. EMD-XXXX) will advance to a 5-digit format (i.e. EMD-XXXXX), and so on. It is currently estimated that the 4-digit codes will be depleted around Spring 2019, at which point the 5-digit format will come into force.
The EM Navigator/Yorodumi systems omit the EMD- prefix.
Related info.:Q: What is EMD? / ID/Accession-code notation in Yorodumi/EM Navigator